AzTrials
AzTrials

Blunt Injury of ThoraxNCT05886946

Abg in Blunt Chest Trauma

An observational study of Blunt Injury of Thorax, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to determine the value of ABG measurments in patients with blunt chest trauma and its role in prognosis of different outcomes and the results would aid the emergency physicians to speed up the management and reduce the cost of diagnosis Read more about this study

Who is it for?
Ages 6 months and older
Conditions the study is for
Blunt Injury of Thorax
What is being tested?
ABG
How many people
150 participants
Where
No sites listed yet
Study dates
1 Jul 2023to 1 Aug 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: blunt chest trauma

Who may be able to join

  • all patient with polytrauma or blunt trauma to chest and thoraco-abdominal area from both genders are included in the study

Who cannot join

  • shocked patients whom were intubated ,patients that had pulmonary disease or heart diseases ,penetrating chest injury ,pregnant female ,patients who do not want to participate in the study

Trial locations and contacts

No sites are listed yet.

asmaa ali mohamed, resident contact

01099698364

reemalii7766@gmail.com

About this study

Official title: Arterial Blood Gas as an Early Screening Tool for Predicting Lung Injury in Blunt Chest Trauma

This study aims to determine the value of ABG measurments in patients with blunt chest trauma and its role in prognosis of different outcomes and the results would aid the emergency physicians to speed up the management and reduce the cost of diagnosis

Being tested
ABG

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ABGOther

    ABG

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Arterial blood gas as an early screening tool for predicting lung injury in blunt chest trauma

    evaluate the diagnostic accuracy of ABG as a screening tool for identifying and early diagnosis lung injury in adult in blunt chest trauma

    Measured: 5 minutes after arrival to emergency

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jun 2023
  2. Study start1 Jul 2023 (estimated)
  3. Primary completion1 Feb 2024 (estimated)
  4. Study completion1 Aug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05886946
Sponsor's protocol ID
Abg in blunt chest
Status last verified
Dec 2022
First submitted
24 May 2023
Last updated
2 Jun 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: no plain now

Questions about this trial

What is this clinical trial studying?

An observational study of Blunt Injury of Thorax, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact asmaa ali mohamed, resident (01099698364, reemalii7766@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Arterial blood gas as an early screening tool for predicting lung injury in blunt chest trauma (time frame: 5 minutes after arrival to emergency). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in